Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Administration Time for Intravenous Enoxaparin 30 mg Bolus

Dosing Guidelines for IV Enoxaparin in STEMI

  • The American College of Cardiology/American Heart Association guidelines recommend an initial 30 mg intravenous bolus of enoxaparin for patients under 75 years of age with ST-elevation myocardial infarction (STEMI) who are receiving fibrinolytic therapy 1, 2, 3
  • This IV bolus should be followed 15 minutes later by subcutaneous injections of 1.0 mg/kg every 12 hours 1, 2, 3
  • For patients 75 years or older, the initial intravenous bolus is eliminated, and the subcutaneous dose is reduced to 0.75 mg/kg every 12 hours 1, 3

Administration Technique

  • The 30 mg IV bolus is typically administered as a direct IV push over 1-2 minutes 4

Special Considerations

  • For patients with renal impairment (creatinine clearance <30 mL/min), dose adjustments are required for the subsequent subcutaneous doses, but the initial IV bolus remains the same 4, 5
  • In patients undergoing percutaneous coronary intervention (PCI), the timing between the last dose of enoxaparin and the procedure is important 5, 6

Common Pitfalls to Avoid

  • Confusing the administration protocols between different anticoagulants (enoxaparin vs. unfractionated heparin vs. fondaparinux) 5
  • Failing to adjust subsequent subcutaneous doses based on age and renal function, even though the initial IV bolus remains standard 4, 6
  • Switching between enoxaparin and unfractionated heparin, which increases bleeding risk 5, 6

REFERENCES